Biotech sector is in a slump for the moment so... @7 multiple X 2024 revs ($75M but for only 1/2 year in U.S. only) so about a $1billion market cap current. So maybe $500M in global revs for 2025 / 26 or $3.5B market cap ($5 share price). 🙏. We need word of treating another indication then it’s off to the races! Any buyout would add a few years rev outlook, of course. I have to believe Rytelo is a prime candidate given its unique MOA and manageable side effects? I hope we hear soon on a new CEO unless Interim CEO Bir hits the ground running.
Market Data 
Markets 
AI
